Mechanistically, in NSCLC, PCAT1 activates the transcription factor SRY-Box transcription factor 2 (SOX2), which directly represses cyclic GMP-AMP synthase (cGAS) promoter activity. Here, SOX2 is linked to non-small cell lung carcinoma.